Income Statement Astal Laboratories Limited

Stocks

MACINTR

INE307N01014

Pharmaceuticals

Market Closed - Bombay S.E. 14:02:31 01/10/2026 +04			5-day change	1st Jan Change
69.54 ^INR	-1.93%		-0.66%	-19.93%

08-14	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-30	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

5a.gQyyfMUkjksna9Z1VWf8URwFwDHvGp3KuOWrrQU6cX0.zDnHNatc3hREWK82Ig-VYXlRrgaoKdubidLR_jZXMhvTNPk3jHzJGFEC4g

Published financial data: ASTAL LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Interest and Dividend Income, Total	2.11M	1.79M	-	-	-
Interest Expense, Total	-	-	-	7.01M	17.06M
Net Interest Income	2.11M	1.79M	-	-7.01M	-17.06M
Other Revenues, Total	-	34.28M	237M	644M	2.5B
Revenues Before Provison For Loan Losses	2.11M	36.07M	237M	637M	2.49B
Total Revenues	2.11M	36.07M	237M	637M	2.49B
Salaries And Other Employee Benefits	852K	648K	-	13.38M	50.22M
Cost of Services Provided, Total	113K	33.79M	225M	484M	2.21B
Depreciation & Amortization - (IS) - (Collected)	146K	79K	295K	2.23M	12.28M
Other Operating Expenses	1.12M	1.23M	-	16.96M	39.92M
Total Operating Expenses	2.23M	35.75M	226M	517M	2.31B
Operating Income	-120K	321K	10.87M	120M	177M
Currency Exchange Gains (Loss)	-	-	-	-	234K
Other Non Operating Income (Expenses)	-	-1K	-	-1K	-2K
EBT, Excl. Unusual Items	-120K	320K	10.87M	120M	177M
Gain (Loss) on Sale of Assets	-50.3K	-	-	-	-
EBT, Incl. Unusual Items	-171K	320K	10.87M	120M	177M
Income Tax Expense	500	156K	3.02M	30.52M	30.21M
Earnings From Continuing Operations	-171K	164K	7.85M	89.25M	147M
Net Income to Company	-171K	164K	7.85M	89.25M	147M
Net Income - (IS)	-171K	164K	7.85M	89.25M	147M
Net Income to Common Incl Extra Items	-171K	164K	7.85M	89.25M	147M
Net Income to Common Excl. Extra Items	-171K	164K	7.85M	89.25M	147M
Per Share Items
Net EPS - Basic	-0.04	0.04	1.55	9.08	8.62
Basic EPS - Continuing Operations	-0.04	0.04	1.55	9.08	8.62
Basic Weighted Average Shares Outstanding	3.97M	3.97M	5.05M	9.83M	17.06M
Net EPS - Diluted	-0.04	0.04	1.55	8.04	7.81
Diluted EPS - Continuing Operations	-0.04	0.04	1.55	8.04	7.81
Diluted Weighted Average Shares Outstanding	3.97M	3.97M	5.05M	11.1M	18.83M
Normalized Basic EPS	-0.02	0.05	1.34	7.62	6.49
Normalized Diluted EPS	-0.02	0.05	1.34	6.75	5.88
Supplemental Items
Total Revenues (As Reported)	2.11M	36.07M	-	644M	2.5B
Effective Tax Rate - (Ratio)	-0.29	48.75	27.78	25.48	17.04
Total Current Taxes	40K	96K	2.94M	29.41M	26.8M
Total Deferred Taxes	-39.5K	60K	82K	1.11M	3.4M
Normalized Net Income	-75.19K	200K	6.79M	74.86M	111M
Non-Cash Pension Expense	26.8K	171K	-	-	-

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	183K	844K	60.76M	17.3M	7.03M
Long-Term Investments - (FS Template)	-	-	-	-	34.36M
Loans and Lease Receivables - (FS Template)	51.12M	37.88M	39.92M	40.92M	41.49M
Other Receivables	-	31.65M	158M	277M	1.57B
Gross Property Plant And Equipment	804K	804K	7.94M	118M	684M
Accumulated Depreciation	-669K	-748K	-1.04M	-3.28M	-53.52M
Net Property Plant And Equipment	135K	56K	6.9M	114M	631M
Goodwill	-	-	-	-	2.03B
Other Intangibles, Total	-	-	-	-	13.68M
Other Current Assets, Total	170K	28.64M	48.37M	162M	854M
Deferred Tax Assets Long-Term (Collected)	70.9K	10K	-	-	-
Other Long-Term Assets, Total	616K	1K	52.03M	21.65M	3.97M
Total Assets	52.29M	99.08M	366M	633M	5.19B
Liabilities
Accounts Payable, Total	-	37.93M	115M	108M	1.24B
Accrued Expenses, Total	10.2K	424K	546K	412K	21.07M
Short-Term Borrowings	-	-	-	127M	290M
Current Portion of Long-Term Debt	-	-	548K	1.18M	14.76M
Current Portion of Leases	-	-	-	-	1.62M
Long-Term Debt	-	-	2.57M	4.56M	186M
Long-Term Leases	-	-	-	-	6.48M
Current Income Taxes Payable	-	-	3.82M	31.31M	72.37M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	8.96M	10.03M	120K	5.34M
Pension & Other Post Retirement Benefits	636K	-	-	-	-
Deferred Tax Liability Non-Current	-	-	72K	1.19M	8.62M
Other Non Current Liabilities	42.3K	-	-	-	-1K
Total Liabilities	688K	47.31M	133M	273M	1.85B
Common Stock, Total	39.74M	39.74M	98.3M	98.3M	422M
Additional Paid In Capital	-	-	115M	115M	2.64B
Retained Earnings	9.78M	9.95M	17.79M	107M	254M
Comprehensive Income and Other	2.08M	2.08M	2.08M	39.38M	22.78M
Total Common Equity	51.6M	51.77M	233M	360M	3.34B
Total Equity	51.6M	51.77M	233M	360M	3.34B
Total Liabilities And Equity	52.29M	99.08M	366M	633M	5.19B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.97M	3.97M	9.83M	9.83M	42.22M
ECS Total Common Shares Outstanding	3.97M	3.97M	9.83M	9.83M	42.22M
Book Value / Share	12.99	13.03	23.74	36.62	79.06
Tangible Book Value	51.6M	51.77M	233M	360M	1.29B
Tangible Book Value Per Share	12.99	13.03	23.74	36.62	30.6
Total Debt	0	0	3.12M	133M	499M
Net Debt	-183K	-844K	-57.64M	115M	492M
Full Time Employees	-	-	-	-	22

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	-171K	164K	7.85M	89.25M	147M
Depreciation, Depletion & Amortization	146K	79K	295K	2.23M	11.97M
Total Depreciation, Depletion & Amortization	146K	79K	295K	2.23M	11.97M
Amortization of Deferred Charges, Total	-	-	-	-	312K
Change In Inventories	-	-	-10.58M	-137M	-58.86M
Change in Accounts Payable	-615K	37.93M	77.22M	-7.4M	453M
Change in Other Net Operating Assets (Collected)	260K	-50.81M	-133M	-105M	-628M
Other Operating Activities	-2.11M	-1.73M	2.58M	33.27M	-103M
Cash from Operations	-2.49M	-14.37M	-55.9M	-125M	-177M
Capital Expenditure	-	-	-59.16M	-57.75M	-13.93M
Sale of Property, Plant, and Equipment	250K	-	-	-	-
Cash Acquisitions	-	-	-	-	-2.96M
Investment in Marketable and Equity Securities, Total	-	-	-	-20.65M	-7.73M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-2.05M	-1M	-
Other Investing Activities, Total	2.11M	1.79M	134K	1.25M	2.92M
Cash from Investing	2.36M	1.79M	-61.08M	-78.14M	-21.7M
Long-Term Debt Issued, Total	-	13.24M	3.3M	3.17M	-
Total Debt Issued	-	13.24M	3.3M	3.17M	-
Long-Term Debt Repaid, Total	-	-	-174K	-547K	-16.57M
Total Debt Repaid	-	-	-174K	-547K	-16.57M
Issuance of Common Stock	-	-	174M	-	-
Other Financing Activities, Total	-	-	-	30.29M	42.37M
Cash from Financing	-	13.24M	177M	32.91M	25.8M
Miscellaneous Cash Flow Adjustments	-	1K	-	-	-
Net Change in Cash	-130K	661K	59.92M	-170M	-173M
Supplemental Items
Cash Interest Paid	-	-	-	7.01M	19.43M
Cash Income Tax Paid (Refund)	500	96K	300K	3.01M	10.21M
Net Debt Issued / Repaid	-	13.24M	3.12M	2.62M	-16.57M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	-0.32	0.22	3.37	17.86	5.05
Return On Equity %	-0.33	0.32	5.5	30.08	7.96
Return on Common Equity	-0.33	0.32	5.5	30.08	7.96
Margin Analysis
Gross Profit Margin %	100	6.99	5.57	24.22	11.4
SG&A Margin	45.78	2.48	0.85	2.39	2.17
Income From Continuing Operations Margin %	-8.12	0.45	3.32	14.02	5.92
Net Income Margin %	-8.12	0.45	3.32	14.02	5.92
Net Avail. For Common Margin %	-8.12	0.45	3.32	14.02	5.92
Normalized Net Income Margin	-3.57	0.55	2.87	11.76	4.46
Asset Turnover
Asset Turnover	0.04	0.48	1.02	1.27	0.85
Short Term Liquidity
Current Ratio	5.05K	2.09	2.36	1.86	1.5
Quick Ratio	5.03K	1.49	1.99	1.25	0.98
Operating Cash Flow to Current Liabilities	-243.93	-0.3	-0.43	-0.47	-0.11
Long Term Solvency
Total Debt/Equity	-	-	1.34	36.86	14.95
Total Debt / Total Capital	-	-	1.32	26.93	13
LT Debt/Equity	-	-	1.1	1.27	5.78
Long-Term Debt / Total Capital	-	-	1.09	0.93	5.03
Total Liabilities / Total Assets	1.32	47.75	36.25	43.17	35.66
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.79	1.61K	556.01	169.15	290.08
Gross Profit, 1 Yr. Growth %	3.79	19.64	1.36K	567.15	82.75
Earnings From Cont. Operations, 1 Yr. Growth %	-384.22	-195.91	4.68K	1.04K	64.81
Net Income, 1 Yr. Growth %	-384.22	-195.91	4.68K	1.04K	64.81
Normalized Net Income, 1 Yr. Growth %	-248.33	-366.67	3.3K	1K	48.03
Diluted EPS Before Extra, 1 Yr. Growth %	-384.22	-195.29	3.69K	417.71	-2.86
Common Equity, 1 Yr. Growth %	-0.31	0.32	350.85	54.22	827.24
Total Assets, 1 Yr. Growth %	-1.48	89.47	269.53	73	718.97
Tangible Book Value, 1 Yr. Growth %	-0.31	0.32	350.85	54.22	258.91
Cash From Operations, 1 Yr. Growth %	33.57	477.45	289.09	124.35	41.39
Capital Expenditures, 1 Yr. Growth %	-	-	-	-2.39	-75.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.18	321.43	959.45	320.1	224.24
Gross Profit, 2 Yr. CAGR %	2.18	11.44	150.09	1.21K	250.14
Earnings From Cont. Operations, 2 Yr. CAGR %	-22.04	65.05	577.41	2.23K	332.96
Net Income, 2 Yr. CAGR %	-22.04	65.05	577.41	2.23K	332.96
Normalized Net Income, 2 Yr. CAGR %	-34.59	98.64	851.58	1.83K	303.95
Diluted EPS Before Extra, 2 Yr. CAGR %	-22.04	64.52	500.88	1.3K	124.21
Common Equity, 2 Yr. CAGR %	-0.1	0.01	112.67	163.69	278.15
Total Assets, 2 Yr. CAGR %	-0.4	36.63	164.61	152.84	276.41
Tangible Book Value, 2 Yr. CAGR %	-0.1	0.01	112.67	163.69	135.27
Cash From Operations, 2 Yr. CAGR %	11.95	177.72	374.01	195.17	78.11
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-51.48
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-10.98	161.42	388.42	570.9	310.03
Gross Profit, 3 Yr. CAGR %	-10.98	7.7	86.55	318.21	580.27
Earnings From Cont. Operations, 3 Yr. CAGR %	-40.72	-16.48	407.03	705.15	864.38
Net Income, 3 Yr. CAGR %	-40.72	-16.48	407.03	705.15	864.38
Normalized Net Income, 3 Yr. CAGR %	-45.76	4.41	411.7	899.37	721.34
Diluted EPS Before Extra, 3 Yr. CAGR %	-41.03	-16.66	368.09	471.77	475.38
Common Equity, 3 Yr. CAGR %	-0.24	0.04	65.21	91.07	300.98
Total Assets, 3 Yr. CAGR %	-0.64	23.41	90.36	129.66	274.1
Tangible Book Value, 3 Yr. CAGR %	-0.24	0.04	65.21	91.07	192.23
Cash From Operations, 3 Yr. CAGR %	-6.07	93.43	210.75	269.16	130.95
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-7.1	64.54	139.74	216.04	314.55
Gross Profit, 5 Yr. CAGR %	-7.1	-3.35	34.57	138.01	168.49
Earnings From Cont. Operations, 5 Yr. CAGR %	26.98	19.96	57.06	216.39	375.99
Net Income, 5 Yr. CAGR %	26.98	19.96	57.06	216.39	375.99
Normalized Net Income, 5 Yr. CAGR %	2.41	46.9	70.51	235.65	365.52
Diluted EPS Before Extra, 5 Yr. CAGR %	33.91	15.44	49.22	157.65	248.71
Common Equity, 5 Yr. CAGR %	-0.48	-0.4	35.03	47.42	130.08
Total Assets, 5 Yr. CAGR %	-0.66	12.87	47.02	64.42	150.04
Tangible Book Value, 5 Yr. CAGR %	-0.48	-0.4	35.03	47.42	90.3
Cash From Operations, 5 Yr. CAGR %	-3.88	37.84	79.47	129.06	148.63